Nobody fully understands RAC's potential.
Triangle have some idea, but they cut it in half arbitrarily.
Mason reported on HC that he had spoken to a medical specialist who said that bisantrene's potential is "beyond comprehension".
PS. Mason isn't a layman in biotech. He has two degrees, both in scientific fields related to human metabolism.
CPACS: Research, Results, Market Comparisons, and Valuations, page-125
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.045(3.07%) |
Mkt cap ! $242.0M | |||
| Open | High | Low | Value | Volume |
| $1.49 | $1.49 | $1.41 | $238.0K | 164.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 2011 | 1 |
View Market Depth
| Last trade - 15.55pm 14/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |